HealthInsu™ — The Model
A prevention subscription, paired with an insurance benefit.
Consumers subscribe to disease-prevention products on a regular basis. If a covered disease occurs, they receive an insurance benefit. From the consumer's point of view, they manage their health while gaining financial protection if illness happens.
Why this model is powerful
Three groups benefit at once. That is what makes it durable.
Health + protection
They subscribe because they want to take care of their health — and because they value the insurance protection that comes with it.
Recurring revenue
Subscription-based consumption creates durable recurring revenue, not one-off shelf sales — and category loyalty compounds.
New short-term group line
A new short-term group insurance line, priced on actual cohort data — small per-cycle premiums, predictable volume, and tighter loss ratios than broad-population underwriting.
How the insurer earns
A new short-term group insurance line, priced on data — not assumption.
The insurer side of HealthInsu™ is not a long-tail life or critical-illness liability. It is structured as a recurring short-term group policy, sized to the subscription cohort and priced on the cohort's own prevention data.
Group short-term contracts
Benefits are typically issued as group short-term insurance contracts. Each subscription cycle generates one small policy premium. Volume scales with the subscription base — predictable, recurring, and cleanly separated from long-tail life or critical-illness liabilities on the insurer's book.
Priced on actual prevention data
Subscribers carry a pre-enrollment baseline (intake examination, biomarkers) and an ongoing usage record. Insurers underwrite against actual cohort data rather than broad-population tables — reducing adverse selection and tightening the loss ratio over the first 12 months of operation.
Zero direct acquisition cost
The insurer reaches the insured pool through the manufacturer's existing subscription channel — no separate marketing spend, no broker commission stack. The benefit ships as part of the product, not as a standalone policy to sell.
Warm leads for traditional lines
Subscribers who complete a year of the structured prevention routine — or who experience a benefit payout — become qualified, opt-in candidates for the insurer's traditional health, cancer, or critical-illness products. The HealthInsu™ cohort becomes a top-of-funnel for the rest of the book.
Actual policy structure (term length, cover scope, premium split, reinsurance treatment) is defined per country and per partner insurer under separate agreement. HealthInsu™ provides the framework; local regulation determines the contract form.
How it works in practice
A six-step structure, run end-to-end by your country team.
Select & validate
Choose a disease-specific prevention product and validate it against your local market and regulation.
Connect clinical
Wire the product to physicians, examinations, and check-up systems.
Subscribe
Consumers subscribe — monthly or through a structured trial program.
Confirm results
Results are confirmed through tests, biomarkers, or follow-up examinations.
Link to insurance
Link the product to an insurance benefit to build trust and reduce buyer hesitation.
Compound trust
A validated product compounds advantage over legacy brand-driven products as the loop runs.
The patent layer
Protected at the structure level, not just the product.
Prevention + insurance, structured
The subscription-to-benefit linkage between preventive products and insurance is protected as a business-model patent — not just a single product claim.
Validation and verification systems
The validation flow (clinic, examination, biomarker, follow-up) is protected as a system patent, layered on top of the business-model claim.
Patent protection is built in multiple layers — typically two to four — so the model holds across jurisdictions and product categories. Country-level licensing terms are defined under separate agreement.
Not a guarantee — a structured risk-sharing program
The framing matters.
HealthInsu™ is not a "we guarantee disease prevention" license. It is a B2B framework that reduces the verification gap consumers feel in the prevention category — through 1-year usage data, conditional compensation structures, and operating standards co-defined per licensee.
Lower buyer hesitation, higher retention
The risk-sharing layer lowers purchase friction for higher-ticket and subscription products, and improves 12-month retention by tying continued use to the benefit structure.
Verified usage, not promises
Consumers see a transparent 1-year structure with defined check-in points — not marketing claims about cure or guaranteed prevention.
Pilot-first, then scale
We typically start with one product and one customer cohort, structured as a 100-person pilot (then 300, then 1,000) over a 12-month observation window. A pilot is designed to measure purchase conversion, retention, satisfaction, repurchase rate, and compensation claim rate — not to confirm medical efficacy. Pilot results inform the full license terms.